83 related articles for article (PubMed ID: 29162772)
21. Mitochondrial NADP
Han SJ; Jang HS; Noh MR; Kim J; Kong MJ; Kim JI; Park JW; Park KM
J Am Soc Nephrol; 2017 Apr; 28(4):1200-1215. PubMed ID: 27821630
[TBL] [Abstract][Full Text] [Related]
22. Isocitrate dehydrogenase mutations in myeloid malignancies.
Medeiros BC; Fathi AT; DiNardo CD; Pollyea DA; Chan SM; Swords R
Leukemia; 2017 Feb; 31(2):272-281. PubMed ID: 27721426
[TBL] [Abstract][Full Text] [Related]
23. Mutations in the IDH2 gene encoding the catalytic subunit of the yeast NAD+-dependent isocitrate dehydrogenase can be suppressed by mutations in the CIT1 gene encoding citrate synthase and other genes of oxidative metabolism.
Gadde DM; McCammon MT
Arch Biochem Biophys; 1997 Aug; 344(1):139-49. PubMed ID: 9244391
[TBL] [Abstract][Full Text] [Related]
24. Hepatic Transcriptomics Reveals that Lipogenesis Is a Key Signaling Pathway in Isocitrate Dehydrogenase 2 Deficient Mice.
Pan JH; Tang J; Redding MC; Beane KE; Conner CL; Cho YJ; Zhao J; Kim JH; Kong BC; Lee JH; Kim JK
Genes (Basel); 2019 Sep; 10(9):. PubMed ID: 31546946
[TBL] [Abstract][Full Text] [Related]
25. Photoactivation of Mutant Isocitrate Dehydrogenase 2 Reveals Rapid Cancer-Associated Metabolic and Epigenetic Changes.
Walker OS; Elsässer SJ; Mahesh M; Bachman M; Balasubramanian S; Chin JW
J Am Chem Soc; 2016 Jan; 138(3):718-21. PubMed ID: 26761588
[TBL] [Abstract][Full Text] [Related]
26. The Role of Mitochondrial NADPH-Dependent Isocitrate Dehydrogenase in Cancer Cells.
Smolková K; Ježek P
Int J Cell Biol; 2012; 2012():273947. PubMed ID: 22675360
[TBL] [Abstract][Full Text] [Related]
27. Wild-type IDH2 promotes the Warburg effect and tumor growth through HIF1α in lung cancer.
Li J; He Y; Tan Z; Lu J; Li L; Song X; Shi F; Xie L; You S; Luo X; Li N; Li Y; Liu X; Tang M; Weng X; Yi W; Fan J; Zhou J; Qiang G; Qiu S; Wu W; Bode AM; Cao Y
Theranostics; 2018; 8(15):4050-4061. PubMed ID: 30128035
[TBL] [Abstract][Full Text] [Related]
28. Clone wars: co-occurrence of IDH2 R140Q and R172K in myelodysplastic syndromes.
Rosso V; Petiti J; Dragani M; Andreani G; Croce E; Lo Iacono M; Saglio G; Fava C; Cilloni D
Ann Hematol; 2020 Apr; 99(4):891-893. PubMed ID: 32016578
[No Abstract] [Full Text] [Related]
29. Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer.
Qiao S; Lu W; Glorieux C; Li J; Zeng P; Meng N; Zhang H; Wen S; Huang P
Oncogene; 2021 Sep; 40(39):5880-5892. PubMed ID: 34349242
[TBL] [Abstract][Full Text] [Related]
30. Absence of IDH2 codon 172 mutation in common human cancers.
Park SW; Chung NG; Han JY; Eom HS; Lee JY; Yoo NJ; Lee SH
Int J Cancer; 2009 Nov; 125(10):2485-6. PubMed ID: 19530255
[No Abstract] [Full Text] [Related]
31. Association between genetic variations of mitochondrial isocitrate dehydrogenase (IDH2) and acute myocardial infarction.
Watany MM; Nagi Abd-Ellatif R; Ezzelregal Abdeldayem M; El-Sayed El-Horany H
Gene; 2022 Jun; 829():146497. PubMed ID: 35447240
[TBL] [Abstract][Full Text] [Related]
32. Altered expression levels of IDH2 are involved in the development of colon cancer.
Lv Q; Xing S; Li Z; Li J; Gong P; Xu X; Chang L; Jin X; Gao F; Li W; Zhang G; Yang J; Zhang X
Exp Ther Med; 2012 Nov; 4(5):801-806. PubMed ID: 23226729
[TBL] [Abstract][Full Text] [Related]
33. IDH2-deficient mice develop spinal deformities with aging.
Chae U; Park NR; Kim ES; Choi JY; Yim M; Lee HS; Lee SR; Lee S; Park JW; Lee DS
Physiol Res; 2018 Jul; 67(3):487-494. PubMed ID: 29527922
[TBL] [Abstract][Full Text] [Related]
34. Malignant transformation by oncogenic K-ras requires IDH2-mediated reductive carboxylation to promote glutamine utilization.
Liu R; Liu P; Bi H; Ling J; Zhang H; Zhang M; Hu Y; Chiao PJ; Huang P; Liu J
Cancer Commun (Lond); 2023 Feb; 43(2):285-289. PubMed ID: 36251752
[No Abstract] [Full Text] [Related]
35. Correction: Transgenic IDH2
Wang D; Zheng L; Cheng BYL; Sin CF; Li R; Tsui SP; Yi X; Ma ACH; He BL; Leung AYH; Sun X
Oncogene; 2023 Apr; 42(16):1331. PubMed ID: 36922683
[No Abstract] [Full Text] [Related]
36. Correction to: Clinical and imaging characteristics of supratentorial glioma with IDH2 mutation.
Ikeda S; Sakata A; Arakawa Y; Mineharu Y; Makino Y; Takeuchi Y; Fushimi Y; Okuchi S; Nakajima S; Otani S; Nakamoto Y
Neuroradiology; 2024 Jun; 66(6):983. PubMed ID: 38679688
[No Abstract] [Full Text] [Related]
37. Codon 172 in the
Sasaki E; Masago K
Gland Surg; 2022 Jun; 11(6):1127-1129. PubMed ID: 35800733
[No Abstract] [Full Text] [Related]
38. Functional alteration of canine isocitrate dehydrogenase 2 (IDH2) via an R174K mutation.
Kawakami S; Ochiai K; Kato Y; Michishita M; Hirama H; Obara R; Azakami D; Watanabe M; Omi T
J Vet Med Sci; 2018 Jan; 80(1):85-91. PubMed ID: 29162772
[TBL] [Abstract][Full Text] [Related]
39. R132 mutations in canine isocitrate dehydrogenase 1 (IDH1) lead to functional changes.
Kawakami S; Ochiai K; Azakami D; Kato Y; Michishita M; Morimatsu M; Ishiguro-Oonuma T; Onozawa E; Watanabe M; Omi T
Vet Res Commun; 2018 Mar; 42(1):49-56. PubMed ID: 29285579
[TBL] [Abstract][Full Text] [Related]
40. Establishment of novel monoclonal antibodies KMab-1 and MMab-1 specific for IDH2 mutations.
Kaneko MK; Morita S; Tsujimoto Y; Yanagiya R; Nasu K; Sasaki H; Hozumi Y; Goto K; Natsume A; Watanabe M; Kumabe T; Takano S; Kato Y
Biochem Biophys Res Commun; 2013 Mar; 432(1):40-5. PubMed ID: 23376717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
